“Changes of peri-implant bone density in relation to local application of alendronate and/or recombinant human bone morphogenetic protein-2: A randomized controlled clinical study”, J Osseointegr, vol. 14, no. 3, pp. 185–193, Sep. 2022, doi: 10.23805/JO.2022.14.30.